|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 06 Jan 2024 | Reference Range | Unit |
|---|---|---|---|
| Leukocytes [#/volume] in Blood by Automated count | 4.1 | 3.4 - 10.5 | 10*3/uL |
| Erythrocytes [#/volume] in Blood by Automated count | 5.1 | 4.5 - 5.5 | 10*6/uL |
| Hemoglobin [Mass/volume] in Blood | 14.0 | 12 - 16 | g/dL |
| Hematocrit [Volume Fraction] of Blood by Automated count | 40.9 | 38 - 54 | % |
| MCV [Entitic volume] by Automated count | 90.0 | 80 - 105 | fL |
| MCH [Entitic mass] by Automated count | 29.4 | 27 - 34 | pg |
| MCHC [Mass/volume] by Automated count | 35.2 | 31 - 36 | g/dL |
| Erythrocyte distribution width [Entitic volume] by Automated count | 42.4 | 36 - 55 | fL |
| Platelets [#/volume] in Blood by Automated count | 423.3 H | 150 - 363 | 10*3/uL |
| Platelet distribution width [Entitic volume] in Blood by Automated count | 388.5 H | 11.6 - 17.4 | fL |
| Platelet mean volume [Entitic volume] in Blood by Automated count | 12.0 | 7.2 - 13.5 | fL |
| Test | 06 Jan 2024 | Reference Range | Unit |
|---|---|---|---|
| Cholesterol [Mass/volume] in Serum or Plasma | 199.6 | 100 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 143.1 | 35 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 114.8 | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 56.2 | 50 - 100 | mg/dL |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| All hematological and lipid parameters are within or near normal limits, except for mildly elevated platelet count and markedly increased platelet distribution width in the most recent test. Lipid profile is stable and within target ranges. No evidence of anemia or leukocytosis. The persistent thrombocytosis and high platelet distribution width may warrant further evaluation for possible reactive or myeloproliferative causes. Clinical correlation is recommended. |